| Serial Number | 98452032 |
| Word Mark | ONCOLYTIC IMMUNOTHERAPY |
| Filing Date | Friday, March 15, 2024 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Thursday, January 23, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Pharmaceutical products for the treatment of cancer; pharmaceutical preparations and biological preparations for the treatment of cancer and immunological disorders; Biopharmaceuticals for the treatment of cancer, namely, antibodies, non-antibody proteins, blood and blood components, stem cells, hormones, blood factors, tumor necrosis factors; Chemical preparations for medical or pharmaceutical purposes, namely, for cancer treatment, oncology and immunotherapy for auto immune diseases; Pharmaceutical products, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing |
| Goods and Services | Pharmaceutical research and development; Providing medical and scientific research information in the fields of oncology, autoimmune disorders, immunotherapy, immunotherapeutics, biotechnology, biopharmaceuticals, pharmaceuticals, therapies, diseases, and disorders |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, March 15, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | Saturday, July 1, 2023 |
| First Use In Commerce Date | Saturday, July 1, 2023 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, March 15, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | Saturday, July 1, 2023 |
| First Use In Commerce Date | Saturday, July 1, 2023 |
| Party Name | CG Oncology, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Irvine, CA 92618 |
| Event Date | Event Description |
| Sunday, March 17, 2024 | NEW APPLICATION ENTERED |
| Friday, August 9, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, September 12, 2024 | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED |
| Thursday, September 12, 2024 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Wednesday, September 25, 2024 | ASSIGNED TO EXAMINER |
| Monday, October 7, 2024 | NON-FINAL ACTION WRITTEN |
| Monday, October 7, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, October 7, 2024 | NON-FINAL ACTION E-MAILED |
| Thursday, January 23, 2025 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Thursday, January 23, 2025 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |